KRAS status analysis and anti-EGFR therapies: is comprehensiveness a biologist's fancy or a clinical necessity?

MeSH terms

• Aged
• Antibodies, Monoclonal / therapeutic use*
• Antineoplastic Agents / therapeutic use
• Carcinoma / drug therapy*
• Carcinoma / genetics
• Carcinoma / pathology
• Colorectal Neoplasms / drug therapy*
• Colorectal Neoplasms / genetics
• Colorectal Neoplasms / pathology
• DNA Mutational Analysis
• Drug Resistance, Neoplasm / genetics
• ErbB Receptors / antagonists & inhibitors
• ErbB Receptors / immunology*
• Genes, ras*
• Humans
• Male
• Medical Futility
• Mutation / physiology
• Neoplasm Metastasis